CMS Office of Patient Advocacy
This article was originally published in The Gray Sheet
Executive Summary
Agency is considering creating an office that would interact with healthcare consumers and disease advocacy groups to inform Medicare and Medicaid policy decisions. The office would resemble FDA's Office of Special Health Issues, which responds to patients' questions on HIV/AIDS, cancer, diabetes therapies and clinical trial enrollment. In addition, OSHI aids policymaking for "special populations," a role CMS also may adopt...